🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Israel discovers antibody combo to fight COVID-19

Researchers at the Laboratory of Human Antibody Research at Tel Aviv University’s Sackler Faculty of Medicine have...

November 26, 2020 | Thursday | News
Pfizer, LianBio collaborate to bring novel therapeutics in Greater China

US-based Pfizer, Inc. and Shanghai-based LianBio have recently announced that they have entered into a collaboration aim...

November 20, 2020 | Friday | News
AUM, Newsoara Biopharma to co-develop next-gen cancer therapeutics

AUM Biosciences (AUM), a global, clinical-stage healthcare company based in Singapore, focused on discovering, acquiring...

November 20, 2020 | Friday | News
Taiwan discovers new gastric cancer biomarkers for tailored therapy

A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua U...

November 17, 2020 | Tuesday | News
Singapore reveals novel method for cancer treatment

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singa...

November 16, 2020 | Monday | News
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...

November 9, 2020 | Monday | News
Celltrion's anti-COVID-19 monoclonal antibody treatment candidate looks promising

Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...

November 9, 2020 | Monday | News
Singapore's single-cell precision medicine company 'Proteona' wins Start-up award

Singapore single cell precision medicine company Proteona has been selected as one of the ten winners of Falling Walls B...

November 9, 2020 | Monday | News
Taiwan accelerates pace of gene-editing technologies into clinical settings

In research endeavors to find a cure for many diseases, CRISPR/Cas9 has becoming a precise tool to modify the DNA in mic...

November 6, 2020 | Friday | News
Australia designs model to link heart disease with T2D

Researchers from Australia's University of Sydney’s School of Project Management within the Faculty...

November 4, 2020 | Wednesday | News
Avatamed, Macrogen focus on personalized precision medicine services in cancer treatment

AVATAMED, a precision medicine service company based in Singapore, represented by CEO Hong Boon Toh, has enter...

November 4, 2020 | Wednesday | News
SK Biopharma and LifeSci Venture Partners to push open innovation

SK Biopharmaceuticals, a global innovative pharmaceutical company based in South Korea, has announced that the company h...

November 4, 2020 | Wednesday | News
PerkinElmer to acquire Horizon Discovery for $383M

PerkinElmer, Inc. and Horizon Discovery Group plc have announced that they have reached an agreement on t...

November 2, 2020 | Monday | News
Ocumension strengthens pipeline for posterior segment eye diseases in China

Hong Kong's Ocumension Therapeutics announced that the Company has entered into a collaboration and exclusive ...

October 30, 2020 | Friday | News
Singapore develops new gelatin microcarrier for cell production

Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise i...

October 29, 2020 | Thursday | News
Samsung Biologics partners with Dinona for potential COVID-19 treatment

Samsung Biologics has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities t...

October 21, 2020 | Wednesday | News
Axis Therapeutics, PharmaEssentia focus on providing TCR-T cell therapy in Taiwan

Axis Therapeutics Limited based in the US and Hong Kong, a joint venture between Athenex, Inc. and Xiangxue Life Science...

October 15, 2020 | Thursday | News
Merck launches VirusExpress platform to push cell and gene therapies

Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentivir...

October 14, 2020 | Wednesday | News